Sensus Healthcare Inc Stock News

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Amphastar Pharmaceuticals (AMPH), AMN Healthcare (AMN) & Sensus Healthcare (SRTS) are well poised to gain.

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Amphastar Pharmaceuticals (AMPH), AMN Healthcare (AMN) & Sensus Healthcare (SRTS) are well poised to gain.

The stock price of Sensus Healthcare Inc (NASDAQ: SRTS) increased by 12.21% in the most recent trading session. This is why it happened.

Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning [Immediately/Date] Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning [Immediately/Date]

VSTO, SRTS, PLCE, and NMRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 30, 2021.

VSTO, SRTS, PLCE, and NMRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 30, 2021.

During the last session, Sensus Healthcare Inc. (NASDAQ:SRTS)s traded shares were 0.39 million, with the beta value of the company hitting 0.54. At the end of the trading day, the stocks price was $6.20, reflecting an intraday gain of 5.26% or $0.31. The 52-week high for the SRTS share is $6.12, that puts it up Sensus Healthcare Inc. (NASDAQ: SRTS) Shares Have Been Up About 60.62% Year-To-Date Since The Beginning Of 2021 Read More »

Sensus Healthcare, Inc. (SRTS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made

Sensus Healthcare, Inc. (SRTS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made

Sensus Healthcare, Inc. (NASDAQ:SRTS) saw a significant decline in short interest in the month of October. As of October 29th, there was short interest totalling 67,300 shares, a decline of 16.4% from the October 14th total of 80,500 shares. Currently, 0.6% of the shares of the company are short sold. Based on an average daily []

Dave & Buster's (PLAY), Sensus Healthcare (SRTS) & Sociedad Quimica y Minera (SQM) are worth buying now for superb earnings acceleration.

Sensus Healthcare (NASDAQ:SRTS) and PolyPid (NASDAQ:PYPD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 12.8% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 9.6% []

PolyPid (NASDAQ:PYPD) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares PolyPid and Sensus Healthcares revenue, earnings per share and valuation. []

Wall Street brokerages expect Sensus Healthcare, Inc. (NASDAQ:SRTS) to report $7.18 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Sensus Healthcares earnings. The lowest sales estimate is $6.00 million and the highest is $7.80 million. Sensus Healthcare posted sales of $5.09 million during the same quarter last []